Comments and Letters

Hepatitis B Screening 

• Support FDA Downclassification of HBV Diagnostic Tests (November 25, 2024)
• Public Comments on Potential Viral Hepatitis Quality Measures in Medicaid (June 7, 2024)
• Letter to the FDA (September 1, 2023)
• HCV Plan Rural Health Impact (September 27, 2023)
• USPSTF: Topic Reconsideration - Screening for Hepatitis B Virus Infection in Adolescents and Adults (October 20, 2022)
• CDC Draft Recommendations for Hepatitis B Screening and Testing in the United States (June 3rd, 2022)
• USPSTF Draft Recommendation Statement: Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults (June 1, 2020)
• USPSTF Draft Research Plan for HBV Infection: Screening in Nonpregnant Adolescents and Adults (January 2, 2019)

 Viral Hepatitis Strategic Plans  

• Final HBU Comments on HHS' Viral Hep Strategic Plan (December 2, 2024)
• Updating the Strategic Plan for Trans-NIH Research to Cure Hepatitis B (January 31, 2022)
• HHS Request for Information: Viral Hepatitis National Strategic Plan 2021-2025 (October 8, 2020)
• HHS Request for Information: Improving Efficiency, Effectiveness, Coordination, and Accountability of HIV and Viral Hepatitis Prevention, Care, and Treatment Programs (March 11, 2019)
• CDC Draft Proposed Framework for the 2016-2020 DVH Strategic Plan (April 3, 2015)
• CDC NCHHSTP Draft Strategic Plan for 2015-2020 (February 24, 2015)

Congressional Sign-on Letters

• House Appropriations Sign-on Letter: FY23 Viral Hepatitis Funding (April 28, 2022)
• House Appropriations Sign-on Letter: FY22 Viral Hepatitis Funding (April 23, 2021)
• Letter to HHS Director, Office of Infectious Disease and HIV/AIDS Policy on Need to Increase Vaccination Rates Against Hepatitis B Among Adults (September 18, 2019)
• Senate Appropriations Sign-on Letter: FY 2020 Viral Hepatitis Funding (April 15, 2019)
• House Appropriations Sign-on Letter: FY 2020 Viral Hepatitis Funding (March 28, 2019)
• House Letter to Office of Management and Budget on FY 2020 Viral Hepatitis Funding (December 18, 2018)
• Letter to NIH Director on Prioritizing Hepatitis B and Liver Cancer Research (November 16, 2017)

Treatment Access

• Letter to CVS: Removal of Vemlidy from CVS Health Formularies (June 9, 2023)
• Response Letter to Optum re: the removal of Vemlidy from their Formulary  (October 20, 2022)
• Letter to Optum re: the Removal of Vemlidy from their Formulary (July 7, 2022)
• Comments on Notice of Benefits and Payment Parameters for 2023 Proposed Rule (January 27, 2022)
• Comments to FDA on Chronic Hepatitis D Virus Infection: Developing Drugs for Treatment Guidance for Industry (December 30, 2019)
• Letter to CVS Caremark re: the Removal of Vemlidy from their Formulary (September 5, 2019)

Opioid Crisis

• Considerations for Proposed Hepatitis C Elimination Program (October 18, 2022)

Immunization

• Support the CMS Rule to Expand Hepatitis B Vaccines (September 9, 2024)
•  Healthy People 2030 Proposed Immunization and Infectious Diseases Objectives (January 10, 2022)
• Letter to the CDC's Advisory Committee on Immunization Practices on the Need for Universal Adult Hepatitis B Vaccination (November 2nd, 2021)
• Prioritizing Adult Hepatitis B Vaccination (July 9, 2020) 
• Comments in Response to HHS Request for Information on Developing the 2020 National Vaccine Plan (October 24, 2019)

Appropriations

• Letter to Senate Appropriations Committee and Senate L-HHS Appropriations Subcommittee re: FY20 Hepatitis B Funding and Report Language (August 16, 2019)

Data and Surveillance 

• Response to CDC 2017 Viral Hepatitis Surveillance Report (September 20, 2019) 
• OMB’s Review of Standards for Maintaining, Collecting, and Reporting Federal Data on Race and Ethnicity (October 31, 2016)
• Proposed 2018 Redesign of the National Health Interview Survey (March 15, 2016)

Discrimination

• Comments in Response to Proposed Rulemaking: Nondiscrimination in Health and Health Education Programs or Activities (Section 1557 of the Affordable Care Act) (August 13, 2019)
• Department of Homeland Security Proposed Rulemaking: Inadmissibility on Public Charge Grounds (December 4, 2018) 
• Opposing the American Health Care Act (March 22, 2017)

Liver Cancer

• NCI's Cancer Moonshot Report (January 12, 2017)

Maternal and Perinatal 

• CMS Request for Information: Maternal and Infant Health Care in Rural Communities (May 31, 2020)
• Consistent Supplemental CDC Funding Support for Perinatal Hepatitis B Programs (May 15, 2019)
• USPSTF Draft Recommendation Statement: Screening for Hepatitis B Virus Infection in Pregnant Women (February 4, 2019)
• USPSTF Draft Research Plan on Screening for HBV Infection Among Pregnant Women (August 9, 2017)

Viral Hepatitis Elimination Planning

• President’s Commission on Combating Drug Addiction and the Opioid Crisis’ Draft Interim Report (August 29, 2017)